Oloxicam (Meloxicam)

Meloxicam, the active ingredient in Oloxicam, is a non‑steroidal anti‑inflammatory drug presented as a 15 mg tablet for oral use. It is indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis and other musculoskeletal conditions in adults.

GNH USA supplies Oloxicam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal disorders. - Osteoarthritis: alleviates joint pain and improves mobility. - Rheumatoid arthritis: decreases joint swelling and stiffness. - Ankylosing spondylitis: reduces spinal pain and inflammation. - Acute musculoskeletal pain: provides short‑term relief of pain and inflammation. - Post‑operative pain: helps manage pain after surgical procedures.

Adverse reactions to meloxicam vary from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: occasional sensation of light‑headedness. - Edema: mild swelling of the lower extremities. - Elevated liver enzymes: transient increase in laboratory values.

Serious or Rare Side Effects: - Peptic ulcer disease or gastrointestinal bleeding. - Severe skin reactions such as Stevens‑Johnson syndrome. - Hepatotoxicity: significant liver injury. - Renal impairment: acute kidney injury or worsening chronic kidney disease. - Cardiovascular events: increased risk of heart attack or stroke.

When prescribing meloxicam, clinicians should consider several safety aspects. - Renal function: assess baseline kidney function and monitor periodically. - Hepatic function: evaluate liver enzymes before initiating therapy. - Cardiovascular risk: use cautiously in patients with history of heart disease. - Gastrointestinal history: avoid in individuals with prior ulcer disease or bleeding. - Concomitant NSAIDs or anticoagulants: increase bleeding risk. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Meloxicam may interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of serious bleeding. - Selective COX‑2 inhibitors (e.g., celecoxib): additive cardiovascular risk. - High‑dose aspirin aspirin: increased gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors/ARBs: may reduce renal perfusion. - Diuretics: potential for decreased kidney function. - Lithium: possible rise in serum lithium levels. - Methotrexate: reduced clearance leading to toxicity. - SSRIs: enhanced risk of gastrointestinal bleeding.